NCT04917731View on ClinicalTrials.gov

Botulinum Toxin Type A for Cold Intolerance Secondary to Digital Amputations and Replantations: A Pilot Study

PHASE1UnknownINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 2, 2021

Primary Completion Date

June 2, 2023

Study Completion Date

June 2, 2023

Conditions
Cold Intolerance
Interventions
DRUG

Botulinum toxin type A

Botox injected at digital artery

Trial Locations (1)

02114

MGH, Boston

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT04917731 - Botulinum Toxin Type A for Cold Intolerance Secondary to Digital Amputations and Replantations: A Pilot Study | Biotech Hunter | Biotech Hunter